Immune response to green fluorescent protein: implications for gene therapy
- PMID: 10455440
- DOI: 10.1038/sj.gt.3300951
Immune response to green fluorescent protein: implications for gene therapy
Abstract
Green fluorescent protein (GFP) is a widely used intracellular reporter molecule to assess gene transfer and expression. A potential use for GFP is as a co-expressed marker, to select and enrich gene-modified cells by flow cytometry. Processed peptides derived from GFP and presented by the major histocompatibility complex on the cell surface could potentially induce T cell immune responses against GFP+ cells. Thus, clinical application of GFP is premature, since in vivo studies on its immunogenicity are lacking. Therefore, we investigated immune responses against EGFP (enhanced-GFP) in two transplantable murine models: the BALB/c (H-2d) BM185 pre-B leukemia and the C57BL/6 (H-2b) EL-4 T cell lymphoma. BM185 and EL-4 cell lines modified to express high levels of EGFP showed drastic reduction of disease development when transplanted into immunocompetent mice. BM185/ EGFP did lead to rapid development of disease in immunodeficient Nu/Nu mice. Mice surviving BM185/EGFP leukemia challenge developed high cytotoxic T lymphocyte (CTL) responses against EGFP-expressing cells. Furthermore, immune stimulation against BM185/EGFP cells could also be induced by immunization with EGFP+ transduced dendritic cells. The effects of the co-expression of EGFP and immunomodulators (CD80 plus GM-CSF) were also investigated as an irradiated leukemia vaccine. EGFP co-expression by the vaccine did not interfere with the development of CTLs against the parental leukemia or with the anti-leukemia response in vivo. These results indicate that the immune response against EGFP may interfere with its applicability in gene insertion/replacement strategies but could potentially be employed for leukemia cell vaccines.
Comment in
-
EGFP-transduced EL-4 cells from tumors in C57BL/6 mice.Gene Ther. 2001 Dec;8(23):1814-5. doi: 10.1038/sj.gt.3301601. Gene Ther. 2001. PMID: 11803403 No abstract available.
Similar articles
-
Combination of CD80 and granulocyte-macrophage colony-stimulating factor coexpression by a leukemia cell vaccine: preclinical studies in a murine model recapitulating Philadelphia chromosome-positive acute lymphoblastic leukemia.Hum Gene Ther. 1999 Sep 1;10(13):2109-22. doi: 10.1089/10430349950017103. Hum Gene Ther. 1999. PMID: 10498243
-
Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells.J Immunol. 2002 Jan 1;168(1):73-80. doi: 10.4049/jimmunol.168.1.73. J Immunol. 2002. PMID: 11751948
-
Immune response to Philadelphia chromosome-positive acute lymphoblastic leukemia induced by expression of CD80, interleukin 2, and granulocyte-macrophage colony-stimulating factor.Hum Gene Ther. 1998 Sep 20;9(14):2049-62. doi: 10.1089/hum.1998.9.14-2049. Hum Gene Ther. 1998. PMID: 9759932
-
Gene therapy with B7.1 and GM-CSF vaccines in a murine AML model.J Pediatr Hematol Oncol. 1997 Nov-Dec;19(6):536-40. doi: 10.1097/00043426-199711000-00012. J Pediatr Hematol Oncol. 1997. PMID: 9407942 Review.
-
Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments.Stem Cell Rev Rep. 2016 Oct;12(5):553-559. doi: 10.1007/s12015-016-9670-8. Stem Cell Rev Rep. 2016. PMID: 27435468 Free PMC article. Review.
Cited by
-
Multiparameter flow cytometric detection and analysis of rare cells in in vivo models of cancer metastasis.Biol Methods Protoc. 2024 Apr 27;9(1):bpae026. doi: 10.1093/biomethods/bpae026. eCollection 2024. Biol Methods Protoc. 2024. PMID: 38737789 Free PMC article.
-
Overcoming Xenoantigen Immunity to Enable Cellular Tracking and Gene Regulation with Immune-competent "NoGlow" Mice.Cancer Res Commun. 2024 Apr 9;4(4):1050-1062. doi: 10.1158/2767-9764.CRC-24-0062. Cancer Res Commun. 2024. PMID: 38592453 Free PMC article.
-
GFP Transfection Alters Protein Expression Patterns in Prostate Cancer Cells: A Proteomic Study.J Fluoresc. 2024 Mar 19. doi: 10.1007/s10895-023-03498-4. Online ahead of print. J Fluoresc. 2024. PMID: 38502405
-
The homing of exogenous hair follicle mesenchymal stem cells into hair follicle niches.JCI Insight. 2023 Dec 22;8(24):e173549. doi: 10.1172/jci.insight.173549. JCI Insight. 2023. PMID: 37917167 Free PMC article.
-
Clonal tracking in cancer and metastasis.Cancer Metastasis Rev. 2024 Jun;43(2):639-656. doi: 10.1007/s10555-023-10149-4. Epub 2023 Nov 1. Cancer Metastasis Rev. 2024. PMID: 37910295 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials